ASTRO 2019 Sign

COVID-19 and Advanced-Stage Cancer Diagnoses

The long-term public health effects of the COVID-19 pandemic go far beyond the disease itself, and even beyond its direct economic and health impacts. It has also had a tremendous impact on the healthcare decisions of patients who have not contracted the virus. Worried about their safety in healthcare facilities, many patients postponed or deferred routine screenings and elective procedures, especially early in the pandemic. Radiation oncology professionals are now seeing the ripple effect of these choices, as patients are arriving to their first treatments with more advanced disease than their providers tended to see before the pandemic. Although many have now resumed scheduling these procedures, the delayed screenings’ effects on patients and their health will persist for months and years to come.

As President and CEO of Radiology Oncology Systems (ROS), John Vano is focused on ensuring that customers receive exceptional service, personal attention, quality, and value. He leads a dedicated team of professionals who share a passion for ROS’s mission: helping healthcare and industrial organizations around the world gain access to high-quality equipment, parts, and service for radiation therapy, diagnostic imaging, and industrial/NDT applications.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top
Submit a Service Request For: